作者
- Bhatt, D.L. (17)
- Califf, R.M. (64)
- Ellis, S.G. (27)
- Granger, C.B. (22)
- Harrington, R.A. (16)
- Kleiman, N.S. (17)
- Lincoff, A.M. (21)
- Moliterno, D.J. (16)
- Topol, E.J. (170)
- White, H.D. (22)
|
總筆數:170
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Introduction |
Topol, E.J.; |
American Heart Journal |
1995-09-01 |
查看 |
| Prevention of cardiovascular ischemic complications with new plateletglycoprotein IIbIIIa inhibitors |
Topol, E.J.; |
American Heart Journal |
1995-09-01 |
查看 |
| Sustained-release local hirulog therapy decreases early thrombosis but notneointimal thickening after arterial stenting |
Muller, D.W.M.;Gordon, D.;Topol, E.J.;Levy, R.J.;Golomb, G.; |
American Heart Journal |
1996-02-01 |
查看 |
| Reuse of coronary angioplasty equipment: Technical and clinical issues |
Mak, K.-H.;Eisenberg, M.J.;Eccleston, D.S.;Cornhill, J.F.;Topol, E.J.; |
American Heart Journal |
1996-03-01 |
查看 |
| Defining the appropriate threshold of creatine kinase elevation afterpercutaneous coronary interventions |
Abdelmeguid, A.E.;Ellis, S.G.;Sapp, S.K.;Whitlow, P.L.;Topol, E.J.; |
American Heart Journal |
1996-06-01 |
查看 |
| Uncoupling clinical outcomes and coronary angiography: A review andperspective of recent trials in coronary artery disease |
Rosenschein, U.;Topol, E.J.; |
American Heart Journal |
1996-10-01 |
查看 |
| Cocaine-induced aortic dissection |
Rashid, J.;Eisenberg, M.J.;Topol, E.J.; |
American Heart Journal |
1996-12-01 |
查看 |
| TIMI grade 3 flow and reocclusion after intravenous thrombolytictherapy: A pooled analysis |
Barbagelata, N.;Granger, C.B.;Oqueli, E.;Suarez, L.D.;Borruel, M.;Topol, E.J.;Califf, R.M.; |
American Heart Journal |
1997-03-01 |
查看 |
| Influence of local delivery of the protein tyrosine kinase receptorinhibitor tyrphostin-47 on smooth-muscle cell proliferation in a ratcarotid balloon-injury model |
Gottsauner-Wolf, M.;Jang, Y.;Lincoff, A.;Cohen, J.L.;Labhasetwar, V.;Poptic, E.J.;Forudi, F.;Guzman, L.A.;DiCorleto, P.E.;Levy, R.J.;Topol, E.J.;Ellis, S.G.; |
American Heart Journal |
1997-03-01 |
查看 |
| Selection of thrombolytic therapy for individual patients: Developmentof a clinical model |
For the GUSTO-I Investigators;Califf, R.M.;Woodlief, L.H.;Harrell, F.E.;Lee, K.L.;White, H.D.;Guerci, A.;Barbash, G.I.;Simes, R.;Weaver, W.D.;Simoons, M.L.;Topol, E.J.; |
American Heart Journal |
1997-06-01 |
查看 |
| Clinical characteristics and long-term outcome of patients in whomcongestive heart failure develops after thrombolytic therapy for acutemyocardial infarction: Development of a predictive model |
From the Division of Cardiology, Department of Medicine, Duke;University Medical Center.;O'Connor, C.M.;Hathaway, W.R.;Bates, E.R.;Leimberger, J.D.;Sigmon, K.N.;Kereiakes, D.J.;George, B.S.;Samaha, J.K.;Abbottsmith, C.W.;Candela, R.J.;Topol, E.J.;Califf, R.M.; |
American Heart Journal |
1997-06-01 |
查看 |
| Heterogeneity of platelet aggregation and major surface receptorexpression in patients with acute myocardial infarction |
Serebruany, V.L.;Gurbel, P.A.;Shustov, A.R.;Ohman, E.;Topol, E.J.; |
American Heart Journal |
1998-09-01 |
查看 |
| Heterogeneity of platelet aggregation and major surface receptorexpression in patients with acute myocardial infarction |
Serebruany, V.L.;Gurbel, P.A.;Shustov, A.R.;Ohman, E.;Topol, E.J.; |
American Heart Journal |
1998-09-01 |
查看 |
| The future of antithrombotic and antiplatelet therapy for ischemic heartdisease |
Topol, E.J.; |
American Heart Journal |
1998-10-01 |
查看 |
| The future of antithrombotic and antiplatelet therapy for ischemic heartdisease |
Topol, E.J.; |
American Heart Journal |
1998-10-01 |
查看 |
| Correlates of in-hospital cost among patients undergoing abdominalaortic aneurysm repair |
Benzaquen, B.S.;Eisenberg, M.J.;Challapalli, R.;Nguyen, T.;Brown, K.J.;Topol, E.J.; |
American Heart Journal |
1998-10-01 |
查看 |
| Correlates of in-hospital cost among patients undergoing abdominalaortic aneurysm repair |
Benzaquen, B.S.;Eisenberg, M.J.;Challapalli, R.;Nguyen, T.;Brown, K.J.;Topol, E.J.; |
American Heart Journal |
1998-10-01 |
查看 |
| The future of antithrombotic and antiplatelet therapy for ischemicheart disease |
Topol, E.J.; |
American Heart Journal |
1998-10-01 |
查看 |
| Use of bedside activated partial thromboplastin time monitor to adjustheparin dosing after thrombolysis for acute myocardial infarction: Resultsof GUSTO-I |
For the GUSTO-I Investigators;Zabel, K.;Granger, C.B.;Becker, R.C.;Bovill, E.G.;Hirsh, J.;Aylward, P.E.;Topol, E.J.;Califf, R.M.; |
American Heart Journal |
1998-11-01 |
查看 |
| Use of bedside activated partial thromboplastin time monitor to adjustheparin dosing after thrombolysis for acute myocardial infarction: Resultsof GUSTO-I |
For the GUSTO-I Investigators;Zabel, K.;Granger, C.B.;Becker, R.C.;Bovill, E.G.;Hirsh, J.;Aylward, P.E.;Topol, E.J.;Califf, R.M.; |
American Heart Journal |
1998-11-01 |
查看 |
| Death and nonfatal reinfarction within the first 24 hours afterpresentation with an acute coronary syndrome: Experience from GUSTO-IIb |
For the GUSTO-IIb Investigators;Kleiman, N.S.;Granger, C.B.;White, H.D.;Armstrong, P.;Ardissino, D.;Van de Werf, F.;Zoldeyhi, P.;Thompson, T.D.;Califf, R.M.;Topol, E.J.; |
American Heart Journal |
1999-01-01 |
查看 |
| Death and nonfatal reinfarction within the first 24 hours afterpresentation with an acute coronary syndrome: Experience from GUSTO-IIb |
For the GUSTO-IIb Investigators;Kleiman, N.S.;Granger, C.B.;White, H.D.;Armstrong, P.;Ardissino, D.;Van de Werf, F.;Zoldeyhi, P.;Thompson, T.D.;Califf, R.M.;Topol, E.J.; |
American Heart Journal |
1999-01-01 |
查看 |
| Death and nonfatal reinfarction within the first 24 hours afterpresentation with an acute coronary syndrome: Experience from GUSTO-IIb |
For the GUSTO-IIb Investigators;Kleiman, N.S.;Granger, C.B.;White, H.D.;Armstrong, P.;Ardissino, D.;Van de Werf, F.;Zoldeyhi, P.;Thompson, T.D.;Califf, R.M.;Topol, E.J.; |
American Heart Journal |
1999-01-01 |
查看 |
| Is all unstable angina the same? Insights from the Coronary AngioplastyVersus Excisional Atherectomy Trial (CAVEAT-I) |
Harrington, R.A.;Califf, R.M.;Holmes, D.R.;Pieper, K.S.;Lincoff, A.M.;Berdan, L.G.;Thompson, T.D.;Topol, E.J.;For the CAVEAT-I Investigators; |
American Heart Journal |
1999-02-01 |
查看 |
| Clinical risk factors for ischemic complications after percutaneouscoronary interventions: Results from the EPIC trial |
Thel, M.C.;Califf, R.M.;Tcheng, J.E.;Sigmon, K.N.;Lincoff, A.M.;Topol, E.J.;Ellis, S.G.;For the EPIC Investigators; |
American Heart Journal |
1999-02-01 |
查看 |
| Is all unstable angina the same? Insights from the Coronary AngioplastyVersus Excisional Atherectomy Trial (CAVEAT-I) |
For the CAVEAT-I Investigators;Harrington, R.A.;Califf, R.M.;Holmes, D.R.;Pieper, K.S.;Lincoff, A.;Berdan, L.G.;Thompson, T.D.;Topol, E.J.; |
American Heart Journal |
1999-02-01 |
查看 |
| Clinical risk factors for ischemic complications after percutaneouscoronary interventions: Results from the EPIC trial |
For the EPIC Investigators;Thel, M.C.;Califf, R.M.;Tcheng, J.E.;Sigmon, K.N.;Lincoff, A.;Topol, E.J.;Ellis, S.G.; |
American Heart Journal |
1999-02-01 |
查看 |
| Smoking status and outcome after primary coronary angioplasty for acutemyocardial infarction |
Hasdai, D.;Lerman, A.;Rihal, C.S.;Criger, D.A.;Garratt, K.N.;Betriu, A.;White, H.D.;Topol, E.J.;Granger, C.B.;Ellis, S.G.;Califf, R.M.;Holmes, D.R.; |
American Heart Journal |
1999-04-01 |
查看 |
| Smoking status and outcome after primary coronary angioplasty for acutemyocardial infarction |
Hasdai, D.;Lerman, A.;Rihal, C.S.;Criger, D.A.;Garratt, K.N.;Betriu, A.;White, H.D.;Topol, E.J.;Granger, C.B.;Ellis, S.G.;Califf, R.M.;Holmes, D.R.; |
American Heart Journal |
1999-04-01 |
查看 |
| Prophylactic lidocaine use in acute myocardial infarction: Incidenceand outcomes from two international trials |
For the GUSTO-I and GUSTO-IIb Investigators;Alexander, J.H.;Granger, C.B.;Sadowski, Z.;Aylward, P.E.;White, H.D.;Thompson, T.D.;Califf, R.M.;Topol, E.J.; |
American Heart Journal |
1999-05-01 |
查看 |
| The impact of the cost-effectiveness study of GUSTO-1 on decisionmaking with regard to fibrinolytic therapy |
Califf, R.M.;Stump, D.;Topol, E.J.;Mark, D.B.; |
American Heart Journal |
1999-05-01 |
查看 |
| The impact of the cost-effectiveness study of GUSTO-1 on decisionmaking with regard to fibrinolytic therapy |
Califf, R.M.;Stump, D.;Topol, E.J.;Mark, D.B.; |
American Heart Journal |
1999-05-01 |
查看 |
| Prophylactic lidocaine use in acute myocardial infarction: Incidenceand outcomes from two international trials |
For the GUSTO-I and GUSTO-IIb Investigators;Alexander, J.H.;Granger, C.B.;Sadowski, Z.;Aylward, P.E.;White, H.D.;Thompson, T.D.;Califf, R.M.;Topol, E.J.; |
American Heart Journal |
1999-05-01 |
查看 |
| Prophylactic lidocaine use in acute myocardial infarction: Incidenceand outcomes from two international trials |
For the GUSTO-I and GUSTO-IIb Investigators;Alexander, J.H.;Granger, C.B.;Sadowski, Z.;Aylward, P.E.;White, H.D.;Thompson, T.D.;Califf, R.M.;Topol, E.J.; |
American Heart Journal |
1999-05-01 |
查看 |
| The impact of the cost-effectiveness study of GUSTO-1 on decisionmaking with regard to fibrinolytic therapy |
Califf, R.M.;Stump, D.;Topol, E.J.;Mark, D.B.; |
American Heart Journal |
1999-05-01 |
查看 |
| Cardiogenic shock complicating acute myocardial infarction: Predictorsof death |
For the GUSTO-I Investigators;Hasdai, D.;Holmes, D.R.;Califf, R.M.;Thompson, T.D.;Hochman, J.S.;Pfisterer, M.;Topol, E.J.; |
American Heart Journal |
1999-07-01 |
查看 |
| Cardiogenic shock complicating acute myocardial infarction: Predictorsof death |
For the GUSTO-I Investigators;Hasdai, D.;Holmes, D.R.;Califf, R.M.;Thompson, T.D.;Hochman, J.S.;Pfisterer, M.;Topol, E.J.; |
American Heart Journal |
1999-07-01 |
查看 |
| Neurosurgical evacuation of intracranial hemorrhage after thrombolytictherapy for acute myocardial infarction: Experience from the GUSTO-I Trial |
For the GUSTO-I Investigators;Mahaffey, K.W.;Granger, C.B.;Sloan, M.A.;Green, C.L.;Gore, J.M.;Weaver, W.;White, H.D.;Simoons, M.L.;Barbash, G.I.;Topol, E.J.;Califf, R.M.; |
American Heart Journal |
1999-09-01 |
查看 |
| Neurosurgical evacuation of intracranial hemorrhage after thrombolytictherapy for acute myocardial infarction: Experience from the GUSTO-I Trial |
For the GUSTO-I Investigators;Mahaffey, K.W.;Granger, C.B.;Sloan, M.A.;Green, C.L.;Gore, J.M.;Weaver, W.;White, H.D.;Simoons, M.L.;Barbash, G.I.;Topol, E.J.;Califf, R.M.; |
American Heart Journal |
1999-09-01 |
查看 |
| Effect of institutional volume and academic status on outcomes ofcoronary interventions: The IMPACT-II experience |
Gilchrist, I.C.;Gardner, L.H.;Muhlestein, J.B.;Arnold, A.M.;Lincoff, A.;Califf, R.M.;Tcheng, J.E.;Topol, E.J.; |
American Heart Journal |
1999-11-01 |
查看 |
| Effect of institutional volume and academic status on outcomes ofcoronary interventions: The IMPACT-II experience |
Gilchrist, I.C.;Gardner, L.H.;Muhlestein, J.B.;Arnold, A.M.;Lincoff, A.;Califf, R.M.;Tcheng, J.E.;Topol, E.J.; |
American Heart Journal |
1999-11-01 |
查看 |
| Effect of institutional volume and academic status on outcomes ofcoronary interventions: The IMPACT-II experience |
Gilchrist, I.C.;Gardner, L.H.;Muhlestein, J.B.;Arnold, A.M.;Lincoff, A.;Califf, R.M.;Tcheng, J.E.;Topol, E.J.; |
American Heart Journal |
1999-11-01 |
查看 |
| Introduction |
Topol, E.J.; |
American Heart Journal |
1999-12-01 |
查看 |
| Insights into the pathophysiology of atherosclerosis and prognosis ofblack Americans with acute coronary syndromes |
Asher, C.R.;Topol, E.J.;Moliterno, D.J.; |
American Heart Journal |
1999-12-01 |
查看 |
| Insights into the pathophysiology of atherosclerosis and prognosis ofblack Americans with acute coronary syndromes |
Asher, C.R.;Topol, E.J.;Moliterno, D.J.; |
American Heart Journal |
1999-12-01 |
查看 |
| Introduction |
Topol, E.J.; |
American Heart Journal |
1999-12-01 |
查看 |
| Cigarette smoking status and outcome among patients with acute coronarysyndromes without persistent ST-segment elevation: Effect of inhibition ofplatelet glycoprotein IIb/IIIa with eptifibatide |
Hasdai, D.;Holmes, D.R.;Criger, D.A.;Topol, E.J.;Califf, R.M.;Wilcox, R.G.;Paolasso, E.;Simoons, M.;Deckers, J.;Harrington, R.A.;The PURSUIT trial investigators; |
American Heart Journal |
2000-03-01 |
查看 |
| Predictors of death and reinfarction at 30 days after primary angioplasty:The GUSTO Ilb and RAPPORT trials |
Brener, S.J.;Ellis, S.G.;Sapp, S.K.;Betriu, A.;Granger, C.B.;Burchenal, J.E.B.;Moliterno, D.J.;Califf, R.M.;Topol, E.J.;GUSTO IIb and RAPPORT Investigators; |
American Heart Journal |
2000-03-01 |
查看 |
| Age and outcome after acute coronary syndromes without persistentST-segment elevation |
Hasdai, D.;Holmes, D.R.;Criger, D.A.;Topol, E.J.;Califf, R.M.;Harrington, R.A.; |
American Heart Journal |
2000-05-01 |
查看 |
| Proteinuria is a key determinant of death in patients with diabetes afterisolated coronary artery bypass grafting |
Marso, S.P.;Ellis, S.G.;Gurm, H.S.;Lytle, B.W.;Topol, E.J.; |
American Heart Journal |
2000-06-01 |
查看 |
| Proteinuria is a key determinant of death in patients with diabetes afterisolated coronary artery bypass grafting |
Marso, S.P.;Ellis, S.G.;Gurm, H.S.;Lytle, B.W.;Topol, E.J.; |
American Heart Journal |
2000-06-01 |
查看 |
| Design of the Blockade of the Glycoprotein IIb/IIIa Receptor to AvoidVascular Occlusion (BRAVO) trial |
Topol, E.J.;Easton, J.;Amarenco, P.;Califf, R.;Harrington, R.;Graffagnino, C.;Davis, S.;Diener, H.C.;Ferguson, J.;Fitzgerald, D.;Shuaib, A.;Koudstaal, P.J.;Theroux, P.;Van de Werf, F.;Willerson, J.T.;Chan, R.;Samuels, R.;Ilson, B.;Granett, J.; |
American Heart Journal |
2000-06-01 |
查看 |
|
|
|
